Current Status and Evolution of Immunotherapy in Glioma Management
International Journal of Medical Sciences · 01.05.2026 · 23 (6) · 2108-2138
DOI: 10.7150/ijms.132708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Medical Sciences, erschienen am 01.05.2026. Verfasst von Jiaying Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Basic Medical College, The Fourth Military Medical University, Xi'an, 710000, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Immunotherapy. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Basic Medical College, The Fourth Military Medical University, Xi'an, 710000, China.
- Department of Neurosurgery, Xijing Hospital, Xi'an, 710000, China.
- State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, 710000, China.
Zitieren
APA
Liu, J., Yang, G., Cao, Z., Qin, H., Zhu, M., Zou, C., Liu, X., He, Y., & Gu, J. (2026). Current Status and Evolution of Immunotherapy in Glioma Management. International Journal of Medical Sciences, 23(6), 2108-2138. https://doi.org/10.7150/ijms.132708
Vancouver
Liu J, Yang G, Cao Z, Qin H, Zhu M, Zou C, et al. Current Status and Evolution of Immunotherapy in Glioma Management. International Journal of Medical Sciences. 2026;23(6):2108-2138. doi:10.7150/ijms.132708
BibTeX
@article{Liu2026,
author = {Liu, Jiaying and Yang, Guangzhao and Cao, Zhengcong and Qin, Haozhe and Zhu, Maorong and Zou, Cheng and Liu, Xiao and He, Yalong and Gu, Jintao},
title = {Current Status and Evolution of Immunotherapy in Glioma Management},
journal = {International Journal of Medical Sciences},
year = {2026},
volume = {23},
number = {6},
pages = {2108--2138},
doi = {10.7150/ijms.132708}
}
EUVIMED